Erianin inhibited the transcriptional level of PIK3R1 by enhancing the protein level of PPAR, thereby suppressing the PI3K/AKT pathway, which resulted in the suppression of acute myeloid leukemia [46]. Here, PIK3CB is linked to acute myeloid leukemia.